A New Supplement for the Immune Response to HPV Infection
Status:
Completed
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate whether a supplement in which ellagic acid plus
annona muricata are combined, may modulate the immune response to high risk HPV infection.
Sixty women will be enrolled in a randomized, controlled study, having a histological
diagnosis of L-SIL correlated with high rish HPV types infection. Main outcome measure is the
activation of onco suppressor protein by the supplement and secondary outcome is the
clearance of HPV infection in the treated group.